DAVID HASSMAN: Open Payments
NPI 1922001841 · BERLIN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$871 in 54 payments from 26 companies in 2025. Trend: 2023 $833 · 2024 $969 · 2025 $871
Food & beverage: $871
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 18 | $182 |
| AstraZeneca Pharmaceuticals LP | 3 | $136 |
| Novo Nordisk Inc | 3 | $53 |
| Alkermes, Inc. | 3 | $50 |
| Otsuka America Pharmaceutical, Inc. | 3 | $47 |
| Lundbeck LLC | 2 | $37 |
| Corcept Therapeutics | 2 | $34 |
| Ardelyx, Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $21 |
| Baxter Healthcare | 1 | $20 |
Products named: EVENITY, FARXIGA, OTEZLA, REXULTI, AIRSUPRA, VIVITROL, Korlym, Rybelsus.
Industry payments across NJ — which companies pay providers there.
